|  |  | |||||
|  |  | |||||
|  |  | |||||
| The Future Prospects for Cell & Gene Therapy - a detailed look at high dose chemotherapy and stem cell support in cancer and genetic disorders by David L. Graham, Dominique Hanssens, Ph.D., Michael Lill, M.D. and Mark E. Sjostrand. |  | |||||
| Cancer remains one of the most important health challenges to the industrialized world and it is little wonder that many companies, hospitals home care providers, physician group practices and others have targeted this field to deliver goods and services that address such a large and complex problem. What was once an experimental procedure known as bone marrow transplantation has been adopted quickly to address a variety of cancers and genetic diseases. The Future Prospects for Cell & Gene Therapy provides detailed, forward-looking projections base upon current incidence estimates and population growth prospects which are summarized in the report. This report comes with a diskette of spreadsheets and charts developed by the authors that can be used to modify assumptions of future conditions. Current Papers Current Status of Stem Cell Laboratory Management: A Review of Issues, Trends and Performance Indicators; April 1998 Reducing Risk and Improving Profitability of New Medical Products (PowerPoint with Notes), presented at the MSMRG, New Orleans, April 3, 2000 Reducing Risk and Improving Profitability of New Pharmaceutical Products, European Pharmaceutical Contractor, November 2000. Patient Focused Practice Management - How to increase the usefulness of patient satisfaction surveys; July 1998 The Cost/Risk Basis for Estimating the Value of Marketing Research for Pharmaceuticals, (Working Paper, The Graham Sjostrand Group 2002) Copyright © 2003-2012, The Graham Sjostrand Group. All rights reserved. |  | |||||
|  |  | |||||
|  |  | |||||
|  |  | |||||
|  |  | |||||
|  |  | |||||
|  |  | |||||
|  |  | |||||
|  |  | |||||
|  |  | |||||
|  |  | |||||
|  |  | |||||
|  |  | |||||
|  |  | |||||
|  |  |  |  |  |  | |